Annual CFO
-$33.46 M
+$46.07 M+57.93%
December 31, 2023
Summary
- As of February 7, 2025, AUPH annual cash flow from operations is -$33.46 million, with the most recent change of +$46.07 million (+57.93%) on December 31, 2023.
- During the last 3 years, AUPH annual CFO has risen by +$36.40 million (+52.10%).
- AUPH annual CFO is now -3217.24% below its all-time high of -$1.01 million, reached on December 31, 2002.
Performance
AUPH Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
$17.03 M
+$1.19 M+7.49%
September 30, 2024
Summary
- As of February 7, 2025, AUPH quarterly cash flow from operations is $17.03 million, with the most recent change of +$1.19 million (+7.49%) on September 30, 2024.
- Over the past year, AUPH quarterly CFO has increased by +$1.19 million (+7.49%).
- AUPH quarterly CFO is now at all-time high.
Performance
AUPH Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
$28.59 M
+$30.31 M+1761.98%
September 30, 2024
Summary
- As of February 7, 2025, AUPH TTM cash flow from operations is $28.59 million, with the most recent change of +$30.31 million (+1761.98%) on September 30, 2024.
- Over the past year, AUPH TTM CFO has increased by +$30.31 million (+1761.98%).
- AUPH TTM CFO is now at all-time high.
Performance
AUPH TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AUPH Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +57.9% | +7.5% | +1762.0% |
| 3 y3 years | +52.1% | +210.8% | +124.7% |
| 5 y5 years | +35.2% | +210.8% | +124.7% |
AUPH Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +78.8% | at high | +136.4% | at high | +118.1% |
| 5 y | 5-year | at high | +78.8% | at high | +131.8% | at high | +118.1% |
| alltime | all time | -3217.2% | +78.8% | at high | +131.8% | at high | +118.1% |
Aurinia Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $17.03 M(+7.5%) | $28.59 M(-1762.0%) |
| Jun 2024 | - | $15.84 M(-185.2%) | -$1.72 M(-91.6%) |
| Mar 2024 | - | -$18.60 M(-229.9%) | -$20.39 M(-39.1%) |
| Dec 2023 | -$33.46 M(-57.9%) | $14.31 M(-207.8%) | -$33.46 M(-10.3%) |
| Sep 2023 | - | -$13.28 M(+369.8%) | -$37.32 M(-5.3%) |
| Jun 2023 | - | -$2.83 M(-91.1%) | -$39.41 M(-38.9%) |
| Mar 2023 | - | -$31.67 M(-403.1%) | -$64.45 M(-19.0%) |
| Dec 2022 | -$79.53 M(-49.6%) | $10.45 M(-168.0%) | -$79.53 M(-31.4%) |
| Sep 2022 | - | -$15.36 M(-44.9%) | -$115.90 M(-17.7%) |
| Jun 2022 | - | -$27.87 M(-40.4%) | -$140.79 M(-6.7%) |
| Mar 2022 | - | -$46.75 M(+80.3%) | -$150.90 M(-4.3%) |
| Dec 2021 | -$157.69 M(+125.7%) | -$25.92 M(-35.6%) | -$157.69 M(+22.7%) |
| Sep 2021 | - | -$40.25 M(+6.0%) | -$128.57 M(+10.1%) |
| Jun 2021 | - | -$37.98 M(-29.1%) | -$116.73 M(+15.8%) |
| Mar 2021 | - | -$53.54 M(-1771.1%) | -$100.79 M(+44.3%) |
| Dec 2020 | -$69.86 M(+9.9%) | $3.20 M(-111.3%) | -$69.86 M(-29.1%) |
| Sep 2020 | - | -$28.42 M(+28.9%) | -$98.47 M(+20.3%) |
| Jun 2020 | - | -$22.04 M(-2.5%) | -$81.83 M(+12.0%) |
| Mar 2020 | - | -$22.61 M(-11.0%) | -$73.04 M(+14.9%) |
| Dec 2019 | -$63.59 M(+23.2%) | -$25.41 M(+115.8%) | -$63.59 M(+22.8%) |
| Sep 2019 | - | -$11.78 M(-11.2%) | -$51.79 M(+0.9%) |
| Jun 2019 | - | -$13.25 M(+0.8%) | -$51.34 M(+1.9%) |
| Mar 2019 | - | -$13.15 M(-3.4%) | -$50.38 M(-2.4%) |
| Dec 2018 | -$51.61 M(+25.4%) | -$13.62 M(+20.2%) | -$51.61 M(+10.0%) |
| Sep 2018 | - | -$11.33 M(-7.8%) | -$46.93 M(+6.4%) |
| Jun 2018 | - | -$12.29 M(-14.5%) | -$44.13 M(-3.7%) |
| Mar 2018 | - | -$14.38 M(+61.0%) | -$45.83 M(+11.3%) |
| Dec 2017 | -$41.17 M(+120.0%) | -$8.93 M(+4.8%) | -$41.17 M(+12.8%) |
| Sep 2017 | - | -$8.53 M(-39.1%) | -$36.50 M(+13.5%) |
| Jun 2017 | - | -$14.00 M(+44.1%) | -$32.16 M(+38.6%) |
| Mar 2017 | - | -$9.71 M(+128.1%) | -$23.21 M(+24.0%) |
| Dec 2016 | -$18.71 M(+5.3%) | -$4.26 M(+1.7%) | -$18.71 M(-3.0%) |
| Sep 2016 | - | -$4.19 M(-17.0%) | -$19.29 M(-5.0%) |
| Jun 2016 | - | -$5.04 M(-3.4%) | -$20.31 M(+7.1%) |
| Mar 2016 | - | -$5.22 M(+7.9%) | -$18.96 M(+6.7%) |
| Dec 2015 | -$17.77 M(+5.1%) | -$4.84 M(-7.1%) | -$17.77 M(+9.2%) |
| Sep 2015 | - | -$5.21 M(+40.9%) | -$16.28 M(+7.9%) |
| Jun 2015 | - | -$3.70 M(-8.1%) | -$15.09 M(-3.1%) |
| Mar 2015 | - | -$4.02 M(+20.1%) | -$15.58 M(-7.9%) |
| Dec 2014 | -$16.91 M(+266.0%) | -$3.35 M(-16.8%) | -$16.91 M(+4.9%) |
| Sep 2014 | - | -$4.02 M(-3.8%) | -$16.11 M(+18.7%) |
| Jun 2014 | - | -$4.18 M(-21.9%) | -$13.57 M(+38.9%) |
| Mar 2014 | - | -$5.35 M(+109.7%) | -$9.77 M(+111.5%) |
| Dec 2013 | -$4.62 M(-29.4%) | -$2.55 M(+71.9%) | -$4.62 M(+62.3%) |
| Sep 2013 | - | -$1.49 M(+289.8%) | -$2.85 M(+9.3%) |
| Jun 2013 | - | -$381.00 K(+89.6%) | -$2.60 M(-47.2%) |
| Mar 2013 | - | -$201.00 K(-74.2%) | -$4.94 M(-24.6%) |
| Dec 2012 | -$6.55 M(+383.0%) | -$779.00 K(-37.3%) | -$6.55 M(-6.6%) |
| Sep 2012 | - | -$1.24 M(-54.2%) | -$7.01 M(+0.4%) |
| Jun 2012 | - | -$2.71 M(+49.8%) | -$6.98 M(+21.2%) |
| Mar 2012 | - | -$1.81 M(+45.8%) | -$5.76 M(+324.8%) |
| Dec 2011 | -$1.36 M | -$1.24 M(+2.3%) | -$1.36 M(+55.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | -$1.21 M(-18.7%) | -$873.60 K(-28.0%) |
| Jun 2011 | - | -$1.49 M(-157.6%) | -$1.21 M(+103.1%) |
| Mar 2011 | - | $2.59 M(-441.1%) | -$597.50 K(-87.0%) |
| Dec 2010 | -$4.58 M(-56.2%) | -$759.90 K(-51.1%) | -$4.58 M(-13.8%) |
| Sep 2010 | - | -$1.55 M(+77.3%) | -$5.32 M(+0.5%) |
| Jun 2010 | - | -$876.20 K(-37.1%) | -$5.29 M(-38.8%) |
| Mar 2010 | - | -$1.39 M(-6.6%) | -$8.64 M(-17.4%) |
| Dec 2009 | -$10.46 M(-39.9%) | -$1.49 M(-2.1%) | -$10.46 M(+0.8%) |
| Sep 2009 | - | -$1.52 M(-63.9%) | -$10.37 M(-3.8%) |
| Jun 2009 | - | -$4.23 M(+31.7%) | -$10.78 M(+1.0%) |
| Mar 2009 | - | -$3.21 M(+128.0%) | -$10.68 M(-38.6%) |
| Dec 2008 | -$17.39 M(-38.9%) | -$1.41 M(-27.3%) | -$17.39 M(-21.7%) |
| Sep 2008 | - | -$1.94 M(-53.1%) | -$22.20 M(-25.1%) |
| Jun 2008 | - | -$4.13 M(-58.4%) | -$29.64 M(-8.3%) |
| Mar 2008 | - | -$9.92 M(+59.6%) | -$32.33 M(+13.6%) |
| Dec 2007 | -$28.46 M(+35.3%) | -$6.21 M(-33.7%) | -$28.46 M(+3.2%) |
| Sep 2007 | - | -$9.37 M(+37.4%) | -$27.57 M(+21.3%) |
| Jun 2007 | - | -$6.82 M(+12.7%) | -$22.72 M(+10.4%) |
| Mar 2007 | - | -$6.05 M(+13.6%) | -$20.59 M(-2.1%) |
| Dec 2006 | -$21.03 M(-0.9%) | -$5.32 M(+17.6%) | -$21.03 M(+0.8%) |
| Sep 2006 | - | -$4.53 M(-3.4%) | -$20.87 M(+6.0%) |
| Jun 2006 | - | -$4.69 M(-27.8%) | -$19.69 M(-5.8%) |
| Mar 2006 | - | -$6.49 M(+25.8%) | -$20.90 M(-1.6%) |
| Dec 2005 | -$21.23 M(+5.4%) | -$5.16 M(+53.9%) | -$21.23 M(-8.9%) |
| Sep 2005 | - | -$3.35 M(-43.1%) | -$23.31 M(-8.5%) |
| Jun 2005 | - | -$5.89 M(-13.6%) | -$25.46 M(+6.0%) |
| Mar 2005 | - | -$6.82 M(-5.8%) | -$24.02 M(+19.2%) |
| Dec 2004 | -$20.15 M(+292.5%) | -$7.24 M(+31.4%) | -$20.15 M(+44.2%) |
| Sep 2004 | - | -$5.51 M(+23.8%) | -$13.98 M(-5.1%) |
| Jun 2004 | - | -$4.45 M(+50.7%) | -$14.73 M(+209.4%) |
| Mar 2004 | - | -$2.95 M(+176.6%) | -$4.76 M(-7.2%) |
| Dec 2003 | -$5.13 M(+409.0%) | -$1.07 M(-83.0%) | -$5.13 M(-33.5%) |
| Sep 2003 | - | -$6.26 M(-213.4%) | -$7.72 M(-386.6%) |
| Jun 2003 | - | $5.52 M(-266.1%) | $2.69 M(-213.5%) |
| Mar 2003 | - | -$3.32 M(-9.1%) | -$2.37 M(+135.4%) |
| Dec 2002 | -$1.01 M(-86.1%) | -$3.66 M(-188.0%) | -$1.01 M(-138.1%) |
| Sep 2002 | - | $4.15 M(+816.3%) | $2.65 M(-364.4%) |
| Jun 2002 | - | $453.30 K(-123.1%) | -$1.00 M(-75.6%) |
| Mar 2002 | - | -$1.96 M(-488.8%) | -$4.11 M(-41.2%) |
| Dec 2001 | -$7.25 M(+25.7%) | - | - |
| Aug 2001 | - | $503.80 K(-119.0%) | -$6.99 M(-21.7%) |
| May 2001 | - | -$2.65 M(-6.6%) | -$8.93 M(+18.9%) |
| Feb 2001 | - | -$2.84 M(+42.5%) | -$7.51 M(+30.2%) |
| Nov 2000 | -$5.77 M(+324.5%) | -$2.00 M(+39.1%) | -$5.77 M(+29.3%) |
| Aug 2000 | - | -$1.43 M(+16.3%) | -$4.46 M(+47.9%) |
| May 2000 | - | -$1.23 M(+11.9%) | -$3.02 M(+19.3%) |
| Feb 2000 | - | -$1.10 M(+60.0%) | -$2.53 M(+86.1%) |
| Nov 1999 | -$1.36 M(-22.7%) | -$689.10 K(-7672.5%) | -$1.36 M(+103.0%) |
| Aug 1999 | - | $9100.00(-101.2%) | -$669.10 K(-1.3%) |
| May 1999 | - | -$744.50 K(-1222.9%) | -$678.20 K(-1122.9%) |
| Feb 1999 | - | $66.30 K | $66.30 K |
| Nov 1998 | -$1.76 M | - | - |
FAQ
- What is Aurinia Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual CFO year-on-year change?
- What is Aurinia Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly CFO year-on-year change?
- What is Aurinia Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals TTM CFO year-on-year change?
What is Aurinia Pharmaceuticals annual cash flow from operations?
The current annual CFO of AUPH is -$33.46 M
What is the all time high annual CFO for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual cash flow from operations is -$1.01 M
What is Aurinia Pharmaceuticals annual CFO year-on-year change?
Over the past year, AUPH annual cash flow from operations has changed by +$46.07 M (+57.93%)
What is Aurinia Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of AUPH is $17.03 M
What is the all time high quarterly CFO for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly cash flow from operations is $17.03 M
What is Aurinia Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, AUPH quarterly cash flow from operations has changed by +$1.19 M (+7.49%)
What is Aurinia Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of AUPH is $28.59 M
What is the all time high TTM CFO for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high TTM cash flow from operations is $28.59 M
What is Aurinia Pharmaceuticals TTM CFO year-on-year change?
Over the past year, AUPH TTM cash flow from operations has changed by +$30.31 M (+1761.98%)